Lechleider Robert

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lechleider Robert's trades of Immunome Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-02
US Immunome Inc (IMNM)
PlS Planned sale
8,239 +5.2%
149.21
US$4,880,372 		8,239 +5.2% 149.21 US$4,880,372
2026-07-07 2026-07-02
US Immunome Inc (IMNM)
PlS Planned sale
7,804 +11.4%
151.06
US$3,413,658 		7,804 +11.4% 151.06 US$3,413,658
2026-07-07 2026-07-02
US Immunome Inc (IMNM)
PlS Planned sale
82,089 +25.3%
238.45
US$795,175 		82,089 +25.3% 238.45 US$795,175
2026-07-02 2026-07-02
US Immunome Inc (IMNM)
PrS Proposed sale
55,000
21.60
US$1,188,000 		55,000 21.60 US$1,188,000
2026-06-29 2026-06-25
US Immunome Inc (IMNM)
PlS Planned sale
14,420 -47.7%
20.66
US$297,917 		14,420 -47.7% 20.66 US$297,917
2026-06-29 2026-06-25
US Immunome Inc (IMNM)
PlS Planned sale
40,580 -57.3%
19.56
US$793,745 		40,580 -57.3% 19.56 US$793,745
2026-06-25 2026-06-25
US Immunome Inc (IMNM)
PrS Proposed sale
55,000
19.73
US$1,085,150 		55,000 19.73 US$1,085,150
2024-11-25 2024-11-21
US Immunome Inc (IMNM)
B Purchase
15,805 +inf%
9.48
US$149,800 		15,805 +inf% 9.48 US$149,800